Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C
This study has been withdrawn prior to enrollment.
Information provided by (Responsible Party):
First received: October 4, 2011
Last updated: February 2, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||August 2014|
|Estimated Primary Completion Date:||March 2014 (Final data collection date for primary outcome measure)|